Noritsu Koki Co., Ltd. operates in the Catalog and mail-order houses sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Noritsu Koki Co., Ltd. with three other
companies in this sector in Japan:
Oisix Ra Daichi Inc
sales of 39.99 billion Japanese Yen [US$354.29 million]
of which 62%
was Express Delivery Business(Oisix)),
(35.77 billion Japanese Yen [US$316.88 million]
of which 100%
was Furima Application Business), and
(62.21 billion Japanese Yen [US$551.15 million]
of which 54%
was Mail-Order Sales).
Noritsu Koki Co., Ltd. reported sales of ¥57.09 billion (US$505.81 million)
March of 2018.
increase of 14.1%
versus 2017, when the company's sales were ¥50.05 billion.
Sales of Drug Discovery saw an increase
that was more than double the company's growth rate: sales were up
38.1% in 2018, from
¥763.00 million to ¥1.05 billion.
Noritsu Koki Co., Ltd. also saw significant increases in sales in
Healthcare (up 22.9% to ¥21.71 billion)
Not all segments of Noritsu Koki Co., Ltd. experienced an increase in sales in 2018:
sales of Other fell 32.3% to ¥245.00 million.
(However, this segment's sales were only a very small portion of the company's overall sales).